Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker GILD
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Kelly Kramer Director | GILD Gilead Sciences, Inc. | 10,376 | $1.8M | 10b5-1 | Nov 12, 2026 | — | Form 144 ↗ |
| Nov 6, 2026 | Keeley M Cain Wettan Officer | GILD Gilead Sciences, Inc. | 3,399 | $569.6K | 10b5-1 | Nov 6, 2026 | Form 4 ↗ 3 days later · 3,399 shares | Form 144 ↗ |
| Nov 4, 2026 | Daniel O'Day Director, Officer | GILD Gilead Sciences, Inc. | 112,429 | $18.8M | 10b5-1 | Nov 4, 2026 | Form 4 ↗ 2 days later · 112,429 shares | Form 144 ↗ |
| Oct 30, 2026 | Daniel O'Day Director, Officer | GILD Gilead Sciences, Inc. | 45,881 | $7.6M | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 3 days later · 30,881 shares | Form 144 ↗ |
| Oct 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $468.7K | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Oct 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $468.7K | 10b5-1 | Oct 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Sep 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $432.6K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Sep 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $435.9K | 10b5-1 | Sep 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Aug 26, 2026 | Anthony Welters Director | GILD Gilead Sciences, Inc. | 18,000 | $2.7M | 10b5-1 | Aug 26, 2026 | Form 4 ↗ 1 day later · 18,000 shares | Form 144 ↗ |
| Aug 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | 5,000 | $738.0K | 10b5-1 | Aug 20, 2026 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Aug 17, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 28,000 | $3.9M | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 28,000 shares | Form 144 ↗ |
| Aug 17, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $415.1K | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Aug 3, 2026 | Daniel O'Day Director, Officer | GILD Gilead Sciences, Inc. | 55,000 | $7.2M | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| Jul 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $389.8K | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Jul 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $389.8K | 10b5-1 | Jul 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Jun 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $376.2K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Jun 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $371.8K | 10b5-1 | Jun 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Jun 1, 2026 | Daniel O'Day Director, Officer | GILD Gilead Sciences, Inc. | 35,000 | $4.7M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| May 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 28,000 | $3.7M | 10b5-1 | May 15, 2026 | Form 4 ↗ 3 days later · 28,000 shares | Form 144 ↗ |
| May 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $396.8K | 10b5-1 | May 15, 2026 | Form 4 ↗ 3 days later · 3,000 shares | Form 144 ↗ |
| Apr 28, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.3M | 10b5-1 | Apr 28, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Apr 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $422.9K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Apr 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $422.9K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Mar 27, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.4M | 10b5-1 | Mar 27, 2026 | Form 4 ↗ 3 days later · 10,000 shares | Form 144 ↗ |
| Mar 16, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $432.7K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Mar 16, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $432.7K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Feb 27, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.4M | 10b5-1 | Feb 27, 2026 | Form 4 ↗ 3 days later · 10,000 shares | Form 144 ↗ |
| Feb 17, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 28,000 | $4.3M | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 1 day later · 28,000 shares | Form 144 ↗ |
| Feb 17, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $463.3K | 10b5-1 | Feb 17, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Feb 5, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 115,640 | $17.3M | 10b5-1 | Feb 5, 2026 | Form 4 ↗ 1 day later · 115,640 shares | Form 144 ↗ |
| Jan 28, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.4M | 10b5-1 | Jan 28, 2026 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Jan 23, 2026 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 115,640 | $15.6M | 10b5-1 | Jan 23, 2026 | Form 4 ↗ 3 days later · 115,640 shares | Form 144 ↗ |
| Jan 22, 2026 | Deborah Telman Officer | GILD Gilead Sciences, Inc. | 29,215 | $3.8M | 10b5-1 | Jan 22, 2026 | — | Form 144 ↗ |
| Jan 20, 2026 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | 5,000 | $617.5K | 10b5-1 | Jan 20, 2026 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Jan 15, 2026 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $372.9K | 10b5-1 | Jan 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Jan 15, 2026 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $372.9K | 10b5-1 | Jan 15, 2026 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Dec 29, 2025 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.2M | 10b5-1 | Dec 29, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Dec 15, 2025 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $366.0K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Dec 15, 2025 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 3,000 | $366.0K | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Nov 28, 2025 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.3M | 10b5-1 | Nov 28, 2025 | Form 4 ↗ 3 days later · 10,000 shares | Form 144 ↗ |
| Nov 28, 2025 | Jeffrey Bluestone Director | GILD Gilead Sciences, Inc. | 5,000 | $625.4K | — | Nov 28, 2025 | Form 4 ↗ 3 days later · 5,000 shares | Form 144 ↗ |
| Nov 26, 2025 | Kelly Kramer Director | GILD Gilead Sciences, Inc. | 5,611 | $713.3K | 10b5-1 | Nov 26, 2025 | Form 4 ↗ 5 days later · 5,611 shares | Form 144 ↗ |
| Nov 17, 2025 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 28,000 | $3.5M | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 1 day later · 28,000 shares | Form 144 ↗ |
| Nov 17, 2025 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 2,500 | $313.1K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 1 day later · 2,500 shares | Form 144 ↗ |
| Nov 13, 2025 | Diane E Wilfong Officer | GILD Gilead Sciences, Inc. | 3,500 | $444.6K | — | Nov 13, 2025 | — | Form 144 ↗ |
| Nov 12, 2025 | Deborah Telman Officer | GILD Gilead Sciences, Inc. | 55,646 | $6.8M | 10b5-1 | Nov 12, 2025 | Form 4 ↗ 1 day later · 53,646 shares | Form 144 ↗ |
| Oct 28, 2025 | Daniel Oday Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.2M | 10b5-1 | Oct 28, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Oct 15, 2025 | Andrew Dickinson Officer | GILD Gilead Sciences, Inc. | 2,500 | $295.2K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ 1 day later · 2,500 shares | Form 144 ↗ |
| Oct 15, 2025 | Johanna Mercier Officer | GILD Gilead Sciences, Inc. | 3,000 | $354.2K | 10b5-1 | Oct 15, 2025 | Form 4 ↗ 1 day later · 3,000 shares | Form 144 ↗ |
| Sep 29, 2025 | Daniel O'Day Officer, Director | GILD Gilead Sciences, Inc. | 10,000 | $1.1M | 10b5-1 | Sep 29, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances